RNA splicing is a key mediator of tumour cell plasticity and a therapeutic vulnerability in colorectal cancer

The influence of mRNA splicing on colon cancer development and progression is unclear. In this study, the authors demonstrate that the SRSF1 splicing factor is essential to sustain the stem cell phenotype of WNT-activated colorectal cancers.

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Adam E. Hall, Sebastian Öther-Gee Pohl, Patrizia Cammareri, Stuart Aitken, Nicholas T. Younger, Michela Raponi, Caroline V. Billard, Alfonso Bolado Carrancio, Aslihan Bastem, Paz Freile, Fiona Haward, Ian R. Adams, Javier F. Caceres, Paula Preyzner, Alex von Kriegsheim, Malcolm G. Dunlop, Farhat V. Din, Kevin B. Myant
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Nature Portfolio 2022-05-01
Cyfres:Nature Communications
Mynediad Ar-lein:https://doi.org/10.1038/s41467-022-30489-z
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg